title: Adjuvant prednisone therapy in pharyngitis: a randomised controlled trial from general practice.
abstract: BACKGROUND
  Acute pharyngitis is a frequent and well-documented complaint in general practice but the associated suffering has remained largely unaddressed in the literature. Evidence, however, from five randomised controlled trials suggests that corticosteroids may be useful in relieving pain and discomfort arising from the condition.
  
  
  OBJECTIVE
  To determine if short-acting oral therapy with prednisone was more effective than placebo in alleviating the suffering from acute pharyngitis in adults in a general practice setting.
  
  
  METHODS
  Randomised placebo-controlled trial.
  
  
  METHODS
  General practice in Israel.
  
  
  METHODS
  Patients with acute pharyngitis were randomised to receive 60 mg prednisone orally for 1 or 2 days, or identical placebo treatment. The main outcome measures were throat pain, measured by a visual analogue scale at 12, 24, 48 and 72 hours after presentation, time off work, fever, dysphagia, recurrence of symptoms and bacterial recurrence.
  
  
  RESULTS
  Patients treated with prednisone experienced more rapid throat pain resolution than those in the placebo group. No adverse effects were reported nor any differences between the two groups regarding either symptom or positive bacterial culture recurrence.
  
  
  CONCLUSIONS
  Short-acting oral steroid therapy is effective for shortening throat pain duration in acute pharyngitis.
authors.affiliation: Department of Family Medicine, Hadassah Hebrew University Medical School, Jerusalem, Israel.
authors.forename: Alexander
authors.initials: A
authors.lastname: Kiderman
authors.forename: John
authors.initials: J
authors.lastname: Yaphe
authors.forename: Joseph
authors.initials: J
authors.lastname: Bregman
authors.forename: Tamar
authors.initials: T
authors.lastname: Zemel
authors.forename: Arthur L
authors.initials: AL
authors.lastname: Furst
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D004305:Dose-Response Relationship, Drug; D005194:Family Practice; D005500:Follow-Up Studies; D006801:Humans; D007557:Israel; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy; D010147:Pain Measurement; D010612:Pharyngitis / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use*; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D011241:Prednisone